Acute Biphenotypic Leukemia (ABL) Active Not Recruiting Phase 2 Trials for Sirolimus (DB00877)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02793544HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation CyclophosphamideTreatment